MIRA Pharmaceuticals

MIRA · NASDAQ

$0.6501+$0.008 (+1.25%)TodayMarket closed ·
Prev close $0.6421

About MIRA

The company is headquartered in Miami, Maryland. The company went IPO on 2023-08-03.

Employees
3
Headquarters
Miami, Maryland
Listed
Aug 3, 2023
Sector
Health Care
Industry
Pharmaceuticals

MIRA key statistics

Market cap
27.32M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
136.92K
Volume
10.46K
Open price
$0.645
High today
$0.6606
Low today
$0.645
52 Week high
$1.80
52 Week low
$0.60

MIRA Pharmaceuticals (MIRA) at a glance

MIRA Pharmaceuticals (MIRA) last traded at $0.6501, with a market cap of 27.32M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.645 and $0.6606. The current price is 0.8% above the day's low and 1.6% below its high.

Volume so far is 10.46K shares, below the average of 136.92K shares a day.

Over the past year MIRA Pharmaceuticals has ranged from $0.60 to $1.80, and now sits 4% of the way up that range.

MIRA Pharmaceuticals met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported -$0.03 per share against an estimate of $0.00.

The average analyst price target is $3.57, 449.1% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 3 analystsAvg $3.57
Low
$3.54
Now
$0.6501
High
$3.67

MIRA earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 26.6% on average.

  1. Q1 FY24: reported -$0.12 per share against an estimate of -$0.102
  2. Q2 FY24: reported -$0.11 per share against an estimate of -$0.102
  3. Q3 FY24: reported -$0.14 per share against an estimate of -$0.1581
  4. Q4 FY24: reported -$0.15 per share against an estimate of -$0.2397
  5. Q1 FY25: reported -$0.11 per share against an estimate of -$0.1479
  6. Q2 FY25: reported -$0.09 per share against an estimate of -$0.1326
  7. Q3 FY25: reported -$0.06 per share against an estimate of -$0.0816
  8. Q2 FY26: reported -$0.03 per share against an estimate of $0.00

MIRA news

  • Vandana Singh

    Why Is MIRA Pharmaceuticals Stock Gaining Tuesday?

  • 12 Health Care Stocks Moving In Monday's After-Market Session

  • 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • 12 Health Care Stocks Moving In Monday's After-Market Session

  • 12 Health Care Stocks Moving In Thursday's Intraday Session

  • Avi Kapoor

    Dow Dips Over 100 Points; US Crude Oil Inventories Surge

  • Avi Kapoor

    Dow Surges Over 100 Points; Charles Schwab Posts Upbeat Earnings

  • Market-Moving News for October 16th

Similar companies

Companies in the same industry as MIRA Pharmaceuticals

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.